China's Top Drug CDMO May be a Big Winner as Supplier for Pf…

图片地址：https://images.tmtpost.com/uploads/images/2021/11/b22dd36f93efd2007461a900ca8788ee_1637196789.jpeg

BEIJING, November 17 (TMTPOST)— Thanks to a large order that signaled the powerful potential as a supplier for Pfizer’s promising Covid treatment, Shenzhen-listed shares of Asymchem Laboratories, a leading Contract Development and Manufacturing Organization (CDMO) that provides integrated solutions to pharmaceutical and biotech companies across the world, rose as much as 10% by daily limit and settled 7%